Sturgis C D, Peterson L R, Warren J R
Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
Am J Clin Pathol. 1997 Aug;108(2):217-21. doi: 10.1093/ajcp/108.2.217.
Enriched broth medium is routinely used as a supplement for agar plate culture of cerebrospinal fluid (CSF). To assess the clinical utility of broth cultures, 151 consecutive CSF bacterial and fungal isolates obtained from 91 patients were retrospectively reviewed for the effect of results on treatment. Treatment decisions associated with individual CSF specimens for which isolates were recovered from thioglycollate broth only were compared with the treatment decisions associated with CSF specimens for which isolates were recovered by agar plate culture. Treatment was defined as initiation of or change in antimicrobial therapy based on the reporting of CSF culture isolates. Thirty-six (24%) of the 151 isolates were recovered in broth only. Three (8%) of these 36 isolates (from 34 patients) resulted in treatment with antimicrobial agents; however, 2 of the 3 treated isolates (Candida tropicalis, Proteus mirabilis) were recovered from a second CSF specimen in agar plate culture within 24 hours. Thus, only a single isolate (3%; Staphylococcus epidermidis) was treated based solely on a positive broth culture result. In contrast, 60 (52%) of the 115 isolates recovered in agar plate culture from 23 (40%) of 57 patients were treated (staphylococci, 28; gram-negative bacilli, 14; Cryptococcus neoformans, 10; Streptococcus pneumoniae, 3; Streptococcus sanguis, 1; other, 4). We conclude that treatment with antimicrobial agents based on isolates recovered from CSF specimens in broth culture alone is infrequent and infer from the data that the use of CSF broth cultures contributes little to treatment decisions.
富集肉汤培养基通常用作脑脊液(CSF)琼脂平板培养的补充。为了评估肉汤培养的临床实用性,对从91例患者中获得的151株连续的脑脊液细菌和真菌分离株进行回顾性分析,以评估结果对治疗的影响。将仅从硫乙醇酸盐肉汤中分离出菌株的单个脑脊液标本的治疗决策与通过琼脂平板培养分离出菌株的脑脊液标本的治疗决策进行比较。治疗定义为根据脑脊液培养分离株的报告开始或改变抗菌治疗。151株分离株中有36株(24%)仅在肉汤中分离得到。这36株分离株中的3株(来自34例患者)导致了抗菌药物治疗;然而,3例接受治疗的分离株中有2株(热带念珠菌、奇异变形杆菌)在24小时内从第二个脑脊液标本的琼脂平板培养中分离得到。因此,仅基于肉汤培养阳性结果治疗的分离株只有1株(3%;表皮葡萄球菌)。相比之下,从57例患者中的23例(40%)的琼脂平板培养中分离得到的115株分离株中有60株(52%)接受了治疗(葡萄球菌28株;革兰氏阴性杆菌14株;新型隐球菌10株;肺炎链球菌3株;血链球菌1株;其他4株)。我们得出结论,仅基于脑脊液标本在肉汤培养中分离出的菌株进行抗菌药物治疗的情况很少见,并且从数据中推断脑脊液肉汤培养对治疗决策的贡献很小。